Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2026The BiochemistOpen Access

Rewinding your cells to fast forward research: advances in Alzheimer’s disease modelling

View Full Paper
Ask AI
Bookmark
Share

Authors

P­Priya ­PrakashUniversity College London

Discussion

Loading...

Member takes

Implication

This article explores induced pluripotent stem cells as a new model for investigating Alzheimer's disease mechanisms, suggesting innovative research avenues.

Key Points

  • To evaluate the efficacy and potential of induced pluripotent stem cells (iPSCs) in modeling Alzheimer’s disease (AD).
  • Exploration of iPSCs derived from adult skin cells of Alzheimer's patients for modeling AD.
  • Comparison of iPSC-derived models with transgenic mouse models.
  • Analysis of amyloid-β and tau aggregation in iPSC-derived cultures.
  • iPSC models provide a renewable source of human neurons that reflect patient-specific genetics.
  • Induced iPSCs allow for high-throughput screening of potential AD treatments.
  • iPSC-derived neurons exhibit limitations in maturity and behavior, impacting their applicability for studying AD.

Cite This Study

Priya ­Prakash (2026) studied this question.

synapsesocial.com/papers/69a134b8ed1d949a99abe39dhttps://doi.org/10.1042/bio_2025_208
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring the Cellular and Molecular Mechanisms Underlying Alzheimer's Disease Utilizing Cerebral Organoids Derived from Patient-specific Induced Pluripotent Stem Cells (iPSCs): A Review with Implications for Surgical Interventions2026
  2. 2Human stem cell transplantation models of Alzheimer’s disease2024 · 14 citations
  3. 3Human Stem Cell-Derived Models of the Alzheimer’s Disease Neuroimmune System2026
  4. 4From Amyloid Exposure to Genetic Causality: Converging hiPSC-Based Models of Alzheimer’s Disease2026
  5. 5Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome2026